In vitro activity of sparfloxacin (AT-4140 and CI-978), a new quinolone antimicrobial agent, against Haemophilus and Gram-positive cocci
- 31 August 1991
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 14 (4) , 355-360
- https://doi.org/10.1016/0732-8893(91)90028-e
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacinAntimicrobial Agents and Chemotherapy, 1990
- In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1990
- Pharmacokinetics of a novel quinolone, AT-4140, in animalsAntimicrobial Agents and Chemotherapy, 1990
- In vitro activity of AT-4140 against clinical bacterial isolatesAntimicrobial Agents and Chemotherapy, 1989
- In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinoloneAntimicrobial Agents and Chemotherapy, 1989